ArticleScientific reports2025
Retrospective study of splenectomy specimens with clinical and pathological features in Southern Iran.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Common and Uncommon Splenic Lesions: A Review.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The spleen is the target of numerous non-neoplastic and uncommon neoplastic lesions. Our study's objective was to evaluate the main indications and clinicopathologic features of a large number of splenectomy specimens from southern Iran, with a focus on splenic neoplasms. This five-year retrospective cross-sectional study was carried out on all splenectomy specimens from two referring centers. The hospital-recorded files and hematoxylin and eosin histopathology slides were reviewed in order to collect demographic information, the primary causes of splenectomy, and histopathological findings. Immunohistochemistry was performed in cases of splenic neoplasms. Of the 803 splenectomy cases, splenic rupture from accidents accounted for 36.3% and hematologic diseases for 31.1% of the procedures. Splenectomies were performed in 24% of cases as a result of staging and surgery for other cancers of the abdominal organs; in general, 3.4% were involved by direct tumor invasion or metastasis. Hydatid cysts, epithelial cysts, pseudocysts, granulomatous inflammation, and storage diseases, in order, accounted for 6.6% of spleens with the non-neoplastic lesions. The 1.8% of cases that were primary splenic neoplasms included 10 vascular tumor cases (including 4 hamartomas, 3 littoral cell angiomas, 1 hemangioma, 1 lymphangioma, and 1 sclerosing angiomatoid nodular transformation) and 4 lymphoma instances, all of which were DLBCL. As the spleen has numerous physiologic functions, it has the capacity to cause numerous traumatic, hematologic, infectious, benign, or malignant primary or metastatic neoplastic lesions. Many different pathologies should therefore be considered when evaluating the pathologic status of splenectomy cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.